Improving Health & Medicine

New Clinical Study Being Launched at the Weizmann Institute of Science

The research may help in developing methodologies that could predict diseases years before their onset

• TAGS: Clinical trials, Mathematics, Molecular genetics

Slider

REHOVOT, ISRAEL—April 8, 2019—The project, led by Prof. Eran Segal and his team in the Department of Computer Science and Applied Mathematics and Department of Molecular Cell Biology, aims to use state-of-the-art artificial intelligence technologies to generate personalized predictions for disease risk factors. The 10K project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals who will be recruited from the Israeli population, and is suitable for Hebrew speakers only.

Prof. Segal and his group believe that the analysis of the data obtained in this study will help in developing methodologies that will influence public health in the future.  

For further information about Project 10K and registration (in Hebrew):
https://www.project10k.org.il/

Prof. Eran Segal’s research is supported by the Crown Human Genome Center, which he heads; the Leona M. and Harry B. Helmsley Charitable Trust; the Else Kroener Fresenius Foundation; the Adelis Foundation; Judith Benattar; Aliza Moussaieff; the Fannie Sherr Fund; the Estate of Zvia Zeroni; and the European Research Council.

Improving Health & Medicine

New Clinical Study Being Launched at the Weizmann Institute of Science

The research may help in developing methodologies that could predict diseases years before their onset

• TAGS: Clinical trials, Mathematics, Molecular genetics

Slider

REHOVOT, ISRAEL—April 8, 2019—The project, led by Prof. Eran Segal and his team in the Department of Computer Science and Applied Mathematics and Department of Molecular Cell Biology, aims to use state-of-the-art artificial intelligence technologies to generate personalized predictions for disease risk factors. The 10K project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals who will be recruited from the Israeli population, and is suitable for Hebrew speakers only.

Prof. Segal and his group believe that the analysis of the data obtained in this study will help in developing methodologies that will influence public health in the future.  

For further information about Project 10K and registration (in Hebrew):
https://www.project10k.org.il/

Prof. Eran Segal’s research is supported by the Crown Human Genome Center, which he heads; the Leona M. and Harry B. Helmsley Charitable Trust; the Else Kroener Fresenius Foundation; the Adelis Foundation; Judith Benattar; Aliza Moussaieff; the Fannie Sherr Fund; the Estate of Zvia Zeroni; and the European Research Council.